Spiro Medical Secures $67 Million Series A Financing to Develop a Neuromodulation System for Asthma

Spiro Medical, Inc., a Newco established to develop the first of its kind Pulmonary Neuromodulation System (PNM) for the ...
MassDevice

Spiro Medical raises $67M Series A to support neuromod tech

Spiro Medical announced today that it closed a $67 million Series A equity financing to support its neuromodulation system.